BioNTech (BNTX) PT Lowered to $136 at Canaccord

August 31, 2026 7:08 AM

Canaccord analyst William Maughan lowered the price target on BioNTech (NASDAQ: BNTX) to $136.00 (from $142.00) while maintaining a Buy rating.

No results found